about
Advances in the treatment of invasive neonatal candidiasisAntifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropeniaClinical Pharmacology Studies in Critically Ill Children.Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and AdultsInvasive fungal infections during the neonatal period: diagnosis, treatment and prophylaxis.Pediatric drug development: formulation considerations.Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
P2860
Q27022585-0E74716B-28E5-42D8-9AC6-2D03F93281C6Q35589175-88635327-CEF7-4BDF-992C-461FECC3E0D7Q36120465-34DFD576-25B1-4D3E-80F9-71888B88B233Q37378093-9E08F0B8-2E5D-4653-A950-1614179575E4Q37973390-BF438772-8B48-48FA-A0D9-C5E546EB01B2Q38183868-AA061C8D-7FFB-49A5-994E-200B8B2DF29BQ38193337-A6C9C085-01FC-45D5-B5F9-F3A32875B303Q38284468-61018394-AED4-4B8E-A168-66998B053688
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pediatric antifungal agents.
@en
Pediatric antifungal agents.
@nl
type
label
Pediatric antifungal agents.
@en
Pediatric antifungal agents.
@nl
prefLabel
Pediatric antifungal agents.
@en
Pediatric antifungal agents.
@nl
P2093
P2860
P1476
Pediatric antifungal agents.
@en
P2093
Cassandra Moran
Daniel K Benjamin
Michael Cohen-Wolkowiez
Phillip B Smith
P2860
P304
P356
10.1097/QCO.0B013E3283321CCC
P577
2009-12-01T00:00:00Z